Additional Metadata
Persistent URL dx.doi.org/10.1016/j.urolonc.2020.01.009, hdl.handle.net/1765/126055
Journal Urologic Oncology
Citation
de Joode, K. (Karlijn), de Ruig-Spakman, J.I. (Jolanda I.), Baktawar, S.S. (Sarwan S.), Leenders, G.J.H.L, Verhagen, P.C.M.S, & van der Veldt, A.A.M. (Astrid A.M.). (2020). Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery. Urologic Oncology. doi:10.1016/j.urolonc.2020.01.009